Document Detail

Use of Aspirin and Clopidogrel After Coronary Artery Bypass Graft Surgery (May).
MedLine Citation:
PMID:  22570427     Owner:  NLM     Status:  Publisher    
OBJECTIVE:To evaluate the evidence for the use of dual antiplatelet therapy (DAPT) with aspirin and clopidogrel following coronary artery bypass graft (CABG) surgery.DATA SOURCES:Literature was accessed through PubMed (1950-November 2011), EMBASE (1976-November 2011), and the Cochrane databases using the terms clopidogrel and coronary artery bypass graft. Citations from available articles were used for additional references and was accessed for abstracts of ongoing studies.STUDY SELECTION AND DATA EXTRACTION:Peer-reviewed studies that evaluated DAPT use after CABG surgery in adult humans were assessed for inclusion.DATA SYNTHESIS:Four randomized clinical trials evaluating surrogate end points and 9 studies (3 subgroup analyses, 6 observational) evaluating clinical outcomes were reviewed. Three clinical trials assessing surrogate end points failed to demonstrate an improvement in graft patency with DAPT use, while 1 clinical trial found an increase in graft patency. As for clinical outcomes, 1 subgroup analysis demonstrated that the benefit of DAPT post-CABG after a non-ST-elevation acute coronary syndrome diminished following surgery, while an observational study demonstrated a trend toward decreased mortality. In post-CABG patients who didnot experience acute coronary syndrome, 2 subgroup analyses proved inconclusive and an observational study found DAPT use to be associated with reducing in-hospital mortality, while another observational study was not associated with reduced long-term mortality. Three observational studies in off-pump CABG patients showed that DAPT use was feasible.CONCLUSIONS:Evidence for DAPT use following CABG is limited to subgroup analyses, observational studies, and trials with surrogate end points. The majority of clinical trials have failed to demonstrate an improvement in graft patency with DAPT. Current evidence does not support the use of DAPT to improve graft patency, and more evidence from randomized controlled trials assessing clinical outcomes is necessary to make definitive recommendations.
Noelle de Leon; Cynthia A Jackevicius
Related Documents :
12406857 - Characterization of high-altitude pulmonary hypertension in the kyrgyz: association wit...
22748647 - Drug-eluting stents compared with bilateral internal thoracic artery grafts for diabeti...
8553877 - Effect of bq123 on vasoconstriction as a result of either hypoxia or endothelin-1 in pe...
22472847 - Percutaneous implantation of edwards sapien valve into pulmonary bioprosthesis (valve-i...
15920657 - Endoluminal recanalization in a patient with phlegmasia cerulea dolens using a multimod...
23953667 - Successful management of postoperative necrotizing pancreatitis after infrarenal abdomi...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-5-8
Journal Detail:
Title:  The Annals of pharmacotherapy     Volume:  -     ISSN:  1542-6270     ISO Abbreviation:  -     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-5-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9203131     Medline TA:  Ann Pharmacother     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
< Western University of Health Sciences, Pomona, CA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression.
Next Document:  Use of Orlistat 60 mg in the Management of Weight Loss Before Bariatric Surgery (June).